Black Maple Capital Management’s Pfizer PFE Stock Holding History

Black Maple Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,000	Closed	-$605K	–	116
2023 Q4	$605K	Hold	21,000	–	–	0.5%	36
2023 Q3	$697K	Buy	+21,000	New	+$743K	0.47%	36

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Black Maple Capital Management's PFE Position: Q1 2024 in Review

Black Maple Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 21,000 shares — an estimated $605K sold.

Black Maple Capital Management first reported a position in PFE in Q3 2023 and held it in 2 quarters. The position peaked at $697K in Q3 2023. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Black Maple Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Black Maple Capital Management sold 21,000 Pfizer shares in Q1 2024, an estimated $605K.
Black Maple Capital Management first reported a position in Pfizer in Q3 2023 and held it in 2 quarters.
Black Maple Capital Management's Pfizer position peaked at $697K in Q3 2023.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Black Maple Capital Management's 13F filing for Q1 2024, filed 15 May 2024.